Cardiology clinic visit increases likelihood of evidence‐based cholesterol prescribing in severe hypercholesterolemia

BACKGROUND: Patients with phenotypic severe hypercholesterolemia (SH), low‐density lipoprotein‐cholesterol (LDL‐c) ≥ 190 mg/dl, atherosclerotic cardiovascular disease (ASCVD) or adults 40–75 years with diabetes with risk factors or 10‐year ASCVD risk ≥20% benefit from maximally tolerated statin ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Groth, Nicole A., Stone, Neil J., Benziger, Catherine P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852174/
https://www.ncbi.nlm.nih.gov/pubmed/33355940
http://dx.doi.org/10.1002/clc.23521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852174/
https://www.ncbi.nlm.nih.gov/pubmed/33355940
http://dx.doi.org/10.1002/clc.23521

Ejemplares similares